Latest News & Features
Americas
AstraZeneca has agreed to let distributor Perrigo Company sell its Entocort (budesonide) drug. 9 December 2015
Generics
Unimed Pharmaceuticals, a subsidiary of life sciences company AbbVie, has slammed generics maker Sandoz with a lawsuit alleging infringement of 11 of its patents. 8 December 2015
Americas
The US government has asked pharmaceutical company Mylan to testify with information on the price of a generic antibiotic product it makes. 7 December 2015
Americas
Valeant Pharmaceuticals has slammed Allergan’s attempt to market a generic version of its Relistor (methylnaltrexone bromide) drug. 4 December 2015
Americas
There were no surprises, but plenty of alarms yesterday following the US Court of Appeals for the Federal Circuit’s decision to reject Sequenom’s request for a re-hearing of its dispute with Ariosa Diagnostics en banc. 3 December 2015
Americas
The US Court of Appeals for the Federal Circuit has rejected Sequenom’s petition to re-hear its dispute with Ariosa Diagnostics en banc. 2 December 2015
Big Pharma
Hedge fund manager Kyle Bass has filed another inter partes review, teaming up with Erich Spangenberg, the former head of patent monetisation firm IPNav, for a second time. 2 December 2015
Medtech
The US Supreme Court has rejected both Nautilus’s and Covidien’s attempt to reverse patent infringement judgments in two separate disputes centring on medical devices. 1 December 2015
Americas
A group of technology companies has urged the US Supreme Court to re-hear the Nautilus v Biosig case, arguing that the US Court of Appeals for the Federal Circuit failed to apply the “reasonable certainty” standard for determining whether a patent claim is indefinite. 30 November 2015
Asia-Pacific
Indian pharmaceutical company Dr Reddy’s has agreed a deal to buy global intellectual property rights to a generic version of GSK’s deep vein thrombosis treatment Arixtra (fondaparinux sodium) as part of a $17.5 million deal with a partner company. 27 November 2015